Bone Morphogenetic Protein 10—A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation

Bone Morphogenetic Protein 10—A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation

Background Patients with atrial fibrillation (AF) face an increased risk of death and major adverse cardiovascular events (MACE). We aimed to assess the predictive value of the novel atrial‐specific biomarker BMP10 (bone morphogenetic protein 10) for death and MACE in patients with AF in comparison...

Full description

Bibliographic Details
Main Authors: Elisa Hennings, Steffen Blum, Stefanie Aeschbacher, Michael Coslovsky, Sven Knecht, Ceylan Eken, Mirko Lischer, Rebecca E. Paladini, Philipp Krisai, Tobias Reichlin, Nicolas Rodondi, Jürg H. Beer, Peter Ammann, Giulio Conte, Maria Luisa De Perna, Richard Kobza, Manuel R. Blum, Matthias Bossard, Peter Kastner, André Ziegler, Christian Müller, Leo H. Bonati, Otmar Pfister, Christine S. Zuern, David Conen, Michael Kühne, Stefan Osswald
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
atrial fibrillation
BMP10
bone morphogenetic protein 10
death
MACE
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.028255

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.122.028255

Similar Items